In the new era of precision medicine, the investigation of disparities is mandatory to tailor preventive strategies. Mounting evidence supports the existence of substantial sex differences in the microvascular and macrovascular complications of diabetes.
In the new era of precision medicine, the investigation of disparities is mandatory to tailor preventive strategies. Mounting evidence supports the existence of substantial sex differences in the microvascular and macrovascular complications of diabetes. 1 Biological differences between men and women can contribute to sex differences in the occurrence and prognosis of diabetes. 1 In general, women tend to have a higher percentage of body fat and often develop peripheral adiposity, whereas men tend to accumulate visceral adipose tissue. 1 Women also have less muscle mass than men and therefore have less muscle available for the uptake of glucose. Sex hormones represent another factor that may differentially regulate glycaemic control in men and women. 1 Lower circulating androgen concentrations have been associated with a higher cardiometabolic risk in men, 2 while higher levels of total estradiol have been associated with increased risk of diabetes in women. 3 Differing diets and physical activities, and genetic and epigenetic factors, can also explain the sex differences in the development of diabetes. 1 The risk of cardiometabolic disorders may differ not only for men and women with diabetes, but also for prediabetic men and women. Prediabetes, which is characterized by impaired glucose metabolism, precedes the development of type 2 diabetes (DM2) and is a risk factor for cardiometabolic disorders. 4 However, the effect of sex differences on the prognosis of prediabetes is controversial 4, 5 and needs to be addressed in order to improve personalized care. Previous studies have evaluated the risk of cardiometabolic disorders in prediabetic men and women [4] [5] [6] and results have been inconsistent. The discrepancy may be due to differences across populations and study designs, the use of different diagnostic criteria for prediabetes and heterogeneous definitions of clinical endpoints. Some studies analysed sex as a covariate without providing sex-specific associations, and did not simultaneously test for multiple outcomes. 4, 6 In this context, a comprehensive and simultaneous investigation of cardiometabolic disorders in prediabetic men and women within the same population, according to various diagnostic criteria, could be crucial to improving the management and prognosis of prediabetic patients.
In this issue of the European Journal of Preventive Cardiology, Parizadeh et al. 7 have found meaningful sex differences in the association between prediabetes and some cardiometabolic outcomes across the diagnostic categories of impaired fasting glucose (IFG ADA, IFG WHO) and impaired glucose tolerance (IGT) among 8498 Iranian participants in the Teheran Lipid and Glucose Study. When using the IFG ADA definition, prediabetic women had an increased risk of hypertension, whereas prediabetic men had an increased risk of chronic kidney disease (CKD). Women with IGT had an increased risk of coronary heart disease (CHD) and men classified by IFG WHO had an increased risk of stroke compared with normoglycaemic participants. Strikingly, the risk of stroke in prediabetic men was as strong as the risk of stroke in diabetic men, and CHD risk in prediabetic women was as strong as CHD risk in diabetic women. These associations did not differ after adjusting for potential confounders that included age, education level, smoking, medications, body mass index, lipid profile and family history of disease. The study confirms previous evidence suggesting an increased risk of CHD in women 8 and an increased risk of stroke in men. 5 If the results of Parizadeh et al. are replicated, IFG ADA could be useful to identify men at risk for CKD and women at risk for hypertension. IFG WHO could help to identify men at risk for stroke, and IGT could improve early identification of women at risk for CHD.
A better understanding of prediabetes and its progression is crucial in order to reduce the global burden of the DM2 epidemic. While some prior research investigated impaired glucose metabolism without much focus on sex differences, Parizadeh et al. concluded that taking sex differences into account could improve the management of prediabetes. Sex-specific tailored preventive strategies might be key to personalized care and can further improve the quality of life in men and women with impaired glucose metabolism. To strengthen these assumptions, sex-specific associations should be systematically reported and several considerations should be taken into account by future communications. As Parizadeh et al. did, one useful approach could be to simultaneously investigate the role of impaired glucose metabolism on various cardiometabolic disorders within the same population. Also, it would be informative to examine the factors that affect trajectories of IFG and IGT, as well as the role of these trajectories on the cardiometabolic health of men and women. Another approach could be to investigate the role of impaired glucose metabolism on general health, using multidimensional measurements that capture a wide spectrum of health aspects. To harmonize comparison among studies and gain insights on the generalizability of results, these comprehensive approaches should be replicated in multiple settings and populations of men and women with different ethnicities and age categories. Importantly, sex-specific mechanisms underlying the progression of impaired glucose metabolism need to be extensively explored. While aiming to enhance personalized medicine, future studies investigating the role of sex differences on the prognosis of prediabetes need to take into consideration a variety of factors that are related to glucose impairment and cardiometabolic disorders. Besides traditional cardiovascular risk factors such as obesity, dyslipidaemia, smoking and physical inactivity, alternative risk factors can be explored and evaluated in order to better identify men and women at increased cardiometabolic risk. [9] [10] [11] Additional information on womenspecific factors such as the presence of polycystic ovary syndrome, premature menopause, history of preeclampsia, history of gestational diabetes and hormone therapy use could also help cluster prediabetic women at high risk who might benefit from particular preventive strategies. Furthermore, studies identifying sexspecific genetic and epigenetic factors could propose novel preventive and therapeutic measures. The efficacy of sex-specific screening programmes and interventions will need to be carefully examined. Adequately powered randomized clinical trials targeting prediabetes should be designed to account for sex differences.
The taxonomy of prediabetes is growing as we learn more about the effects of this condition on cardiometabolic health. The lack of a universally accepted definition for prediabetes has led to major variations in the prevalence of this condition. Still, each definition of prediabetes may have an independent prognostic value, thereby the idea of selecting unique diagnostic criteria from the currently available definitions may not be appropriate. Specific cutoff values across the continuum of impaired glucose metabolism could help identify different groups of men and women at high cardiometabolic risk. This could further improve the personalized management of men and women with prediabetes.
In conclusion, one's sex can substantially affect the occurrence, development and management of prediabetes. Current observations of sex disparities in the prognosis of prediabetes suggest the potential need for sex-specific screening and intervention programmes to improve the personalized care of men and women with this condition. In the future, basic and clinical research efforts should provide novel insights into the role of sex differences in prediabetes. Guidelines for the management of impaired glucose metabolism should consider sex-specific recommendations. Sex-specific approaches in prediabetes and diabetes may lead to a more effective use of clinical and public health resources.
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